Innate Pharma Email Format

Biotechnology ResearchProvence-alpes-côte D'azur, France51-200 Employees

Innate Pharma S.A. is a global, clinical-stage biotechnology company focused on oncology, developing therapeutic antibodies that harness the immune system to fight cancer. The organization emphasizes natural killer cell biology, the tumor microenvironment, tumor antigens, and antibody engineering, building a diversified proprietary portfolio and maintaining major alliances with leaders in the biopharmaceutical industry. Based in Marseille, France, Innate Pharma is listed on both Euronext Paris and Nasdaq.

Its pipeline targets cancers with high unmet medical need and comprises candidates that are potentially first-in-class or best-in-class, spanning clinical and preclinical efforts. Notable programs include IPH4502, a Nectin-4 antibody-drug conjugate in solid tumors; lacutamab, an anti-KIR3DL2 antibody for cutaneous and peripheral T cell lymphomas; and monalizumab, an anti-NKG2A antibody developed with AstraZeneca for non-small cell lung cancer. In 2026 the company has continued to participate in industry events and advance its development activities.

Sign up for free to view info

Company overview Employee directory